Strategy·

People·

Execution

Balance humanity
and high performance.
Make healthcare work, better.

CEOs and their investors partner with FMG Leading to build market-leading healthcare companies that deliver differentiated patient outcomes and sustainable business results.

The Reality

Most healthcare organizations don't fail on strategy.
They fail in the space between strategy and execution.

In PE-backed healthcare, CEOs inherit an investment thesis built in a deal model — with 100 days to align their team around a new growth strategy and evaluate their ability to execute. Investors carry a similar gap from the other side: a compelling deal model that rarely implements perfectly, given the dynamic nature of human behavior and market conditions.

Close that gap, the company thrives, enterprise value grows, and health outcomes improve. Leave it open, and from day one, value quickly walks out the door. Market-leading platforms know how to deliver the right data to the right people at the right time to drive durable performance outcomes.

“Bringing in experts like FMG Leading helps us evaluate talent around a deal, both in terms of existing talent in a company, and also talent we bring to a company post-acquisition. So often, the human element is the differentiator between failure and success; between an ‘A outcome’ and a ‘C+ outcome’.”

Oliver Moses — Managing Partner, WindRose Health Investors

Mitigate Risk. Accelerate Growth.

Compress the time between investment and execution.

Healthcare CEOs and their teams are tasked with a unique challenge: drive financial and human performance equally. When both are in balance, organizations thrive. When they’re not, growth stalls, mission-focus erodes, and both business and health outcomes suffer.

Entrepreneurs, executives, and investors across the healthcare ecosystem partner with FMG Leading to bring clarity where it’s missing, and build momentum where it’s lost. They trust us to help them create clear strategies, eliminate expensive problems, and turn insights into action.

First 100 Days

CEOs hit alignment milestones inside the onboarding window — not at month 18.

3–5 Years

Hold-period value creation runs against a tested playbook, not a wished-for one.

Premium

Exit narratives credible to buyers. Leadership demonstrably capable.

One Firm

Diligence, onboarding, value creation, exit — partnership across the entire arc.

“The new growth trajectory at ImmunoTek created a multitude of obstacles …. and also a multitude of opportunities. The team at FMG Leading helped us effectively navigate that course.”

Jerome Parnell III — Vice Chairman and Founder, ImmunoTek

Insight driven. Advisory led. Outcome focused.

Integrated solutions that help you make better, faster decisions.

Strategy without intelligence is opinion. Intelligence without testing is theory. A tested strategy without leadership alignment never executes. CEOs and investors get all three capabilities under one roof — built specifically for PE-backed healthcare.

Connecting market intelligence, organizational health data, and outside-in competitive context under one platform — along with experienced advisory that turns insights into action — gives healthcare-focused executives a true competitive advantage.

01

Market Intelligence

Sector dynamics, competitive positioning, payer-mix shifts, patient flow patterns — calibrated to healthcare-specific signals so every strategy conversation rests on something firmer than opinion.

02

Strategy Development & Testing

A validated growth playbook your leadership team helps shape — pressure-tested against real market conditions, scenario-modeled, and de-risked before anyone executes against it.

03

Leadership Alignment & Activation

The activation layer no other firm provides. Leadership teams move from informed to genuinely aligned — oriented around the strategy, accountable to it, capable of driving it through every level of the organization.

“FMG Leading is really a strategic business partner to us. They bring a broad perspective both of the healthcare industry, as well as their experience working across the healthcare continuum, to enable solutions that are customized to what DispatchHealth needs.”

Jennifer Webster — CEO, DispatchHealth

Performance Acceleration Partners

Add value throughout the entire lifecycle.

Healthcare CEOs and investors need predictable results now more than ever. They need an integrated partner purpose-built to help them solve costly and complex problems across the healthcare ecosystem.

Executives want trusted partners that understand their unique business context and challenges. Leaders that can help them turn insights into action, mitigate risk, and add value at each stage of the lifecycle.

Pre-Close

Diligence

Close with conviction and confidence.

First 100 Days

Onboarding

Activate from day one.

3-5 Year Hold Period

Value Creation

Where the multiple gets made — or lost.

6–12 months out

Exit Planning

Position for a premium multiple.

The Difference

Healthcare executives and investors choose FMG Leading to help them optimize performance wherever they are in the growth lifecycle, from entry to exit.

While our work is rooted in investor-backed healthcare, leaders across the healthcare ecosystem trust us to help them solve expensive problems, improve operating outcomes, and deliver a measurable ROI.

“Our relationship with FMG Leading has been part of the consistent execution of performance for all our portfolio companies. They help us create a roadmap for how a portfolio company is going to perform, and help us develop a conversation that gives us alignment between private equity owners, the board, and the management team, to ensure we are all working together.”

Eric Larson — Co-Founder, Chairman & Co-CEO, Tilia Holdings

Built for Both Sides of the Table

Whichever side you sit on, value is built the same way.

Portfolio Executives

Lead a PE-backed healthcare company with conviction.

Bringing on a new investor means increased expectations and a faster pace. CEOs working with FMG Leading walk into the boardroom with a strategy their team is aligned around and genuinely owns — and a clear growth roadmap that they’re ready to execute at scale.

Private Equity Investors

Protect the multiple, from diligence through exit.

PE executives and operating partners working with FMG Leading get the activation layer the strategy firms don’t provide — and the sector expertise generalists can’t match. Investors close with conviction, onboard with structure, and exit with a credible growth story.

“In terms of understanding what you’ve got, where you’re at, and the pathways or multiple options around the big levers and value points that drive performance, FMG Leading is bar none the best in my experience; it’s extraordinary.”

Andrew Hayek — CEO, Triple Aim Partners · Former CEO, OptumHealth and SCA Health

Field Notes

Sector intelligence built for the leaders making the calls.

Insight Brief

4 min read

Pre-Exit Prep Remains Essential for Healthcare Investors in 2026

With AI advances, and younger generations’ preference for more digital, on-demand services, it’s only a matter of time before hybrid becomes a dominant force in the healthcare industry.

Insight Brief

4 min read

Hybrid Remains the Investable Healthcare Opportunity

With AI advances, and younger generations’ preference for more digital, on-demand services, it’s only a matter of time before hybrid becomes a dominant force in the healthcare industry.

Insight Brief

2 min read

Leading Hybrid Healthcare: People-led Strategies that Ensure Virtual and Home-based Care Delivery Models Capture Value and Improve Outcomes

Provider organizations today have a sizable opportunity to serve as leaders in the delivery of hybrid healthcare, although frequently overlooked barriers threaten to jeopardize investments in the space.

Translate Strategy into Success

One conversation.
One engagement.

Test our integrated model on the strategy you’re being asked to execute right now. Surface the intelligence. Pressure-test the playbook. Align the leadership team. See what an optimized, high-performance organization can actually deliver.

Balance humanity
and high performance.
Make healthcare work, better.

Most healthcare organizations don't fail on strategy.
They fail in the space between strategy and execution.